Structural and functional characterization of a specific antidote for ticagrelor.

Blood
Andrew BuchananS Nylander

Abstract

Ticagrelor is a direct-acting reversibly binding P2Y12 antagonist and is widely used as an antiplatelet therapy for the prevention of cardiovascular events in acute coronary syndrome patients. However, antiplatelet therapy can be associated with an increased risk of bleeding. Here, we present data on the identification and the in vitro and in vivo pharmacology of an antigen-binding fragment (Fab) antidote for ticagrelor. The Fab has a 20 pM affinity for ticagrelor, which is 100 times stronger than ticagrelor's affinity for its target, P2Y12. Despite ticagrelor's structural similarities to adenosine, the Fab is highly specific and does not bind to adenosine, adenosine triphosphate, adenosine 5'-diphosphate, or structurally related drugs. The antidote concentration-dependently neutralized the free fraction of ticagrelor and reversed its antiplatelet activity both in vitro in human platelet-rich plasma and in vivo in mice. Lastly, the antidote proved effective in normalizing ticagrelor-dependent bleeding in a mouse model of acute surgery. This specific antidote for ticagrelor may prove valuable as an agent for patients who require emergency procedures.

References

Sep 11, 2007·Bioorganic & Medicinal Chemistry Letters·Brian SpringthorpePaul A Willis
Jun 26, 2009·Journal of Thrombosis and Haemostasis : JTH·J J J VAN GiezenP J Greasley
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Jun 17, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Renli TengKathleen Butler
May 11, 2011·Protein Science : a Publication of the Protein Society·Sean W Fanning, James R Horn
Jun 9, 2011·Journal of Thrombosis and Haemostasis : JTH·F PrüllerE Mahla
Jul 6, 2011·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Henrik SillénPatty Davis
Aug 28, 2012·European Heart Journal·UNKNOWN Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)Doron Zahger
Mar 12, 2013·Blood·Felix SchieleTobias Litzenburger
Aug 8, 2013·Journal of Cardiothoracic and Vascular Anesthesia·Magnus DalénJan van der Linden
Apr 29, 2014·Journal of the American College of Cardiology·Marco CattaneoSven Nylander
Nov 6, 2014·The New England Journal of Medicine·Jack E AnsellJames C Costin
Jan 8, 2015·The New England Journal of Medicine·Anne GodierPascale Gaussem

❮ Previous
Next ❯

Citations

Jan 23, 2016·Interactive Cardiovascular and Thoracic Surgery·Ugur KucukMustafa Aparci
Jun 17, 2016·CPT: Pharmacometrics & Systems Pharmacology·J AlmquistP Gennemark
Sep 30, 2016·Expert Opinion on Pharmacotherapy·Piotr AdamskiJacek Kubica
Sep 4, 2016·Scandinavian Cardiovascular Journal : SCJ·Emma C Hansson, Anders Jeppsson
Oct 28, 2016·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Susanne PehrssonSven Nylander
Mar 23, 2017·Journal of Thrombosis and Haemostasis : JTH·S PehrssonS Nylander
Feb 6, 2017·Journal of Clinical Pathology·Leyla CalmetteAnne Godier
Sep 1, 2018·Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy·Vivek GulatiRobert Middleton
Aug 5, 2017·Circulation. Cardiovascular Interventions·M Urooj ZafarJuan J Badimon
Nov 11, 2015·Circulation. Cardiovascular Interventions·Dirk Sibbing, Steffen Massberg
Oct 26, 2018·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Michael KremkeCarl-Johan Jakobsen
Jan 7, 2020·Médecine sciences : M/S·Yves GruelPeter Lenting
Mar 20, 2020·Journal of Clinical Medicine·Guillaume Porta BoneteAnne-Céline Martin
Mar 5, 2016·Drugs & Aging·Bianca Rocca, Steen Husted
Jun 1, 2017·Vox Sanguinis·T Gremmel, S Panzer
Mar 19, 2019·The New England Journal of Medicine·Deepak L BhattJohn S Lee
Oct 27, 2017·EFORT Open Reviews·Rafik YassaPaul Dunkow
Jan 10, 2018·Journal of Thrombosis and Haemostasis : JTH·M U ZafarG Escolar
Jul 28, 2020·Journal of Clinical Medicine·Anne GodierThe French Working Group On Perioperative Haemostasis Gihp Group
Apr 24, 2017·JACC. Basic to Translational Science·Richard C Becker
Apr 24, 2017·JACC. Basic to Translational Science·George O AngheloiuCarl Whatling
Nov 19, 2019·European Journal of Pharmacology·Anne-Céline MartinChristilla Bachelot-Loza
May 25, 2021·Journal of Cardiac Surgery·Ahmad MakhdoumBobby Yanagawa
Dec 10, 2016·The Journal of Physical Chemistry. B·D'Artagnan GreeneRay Luo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.